NCT01352221View on ClinicalTrials.gov

Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)

PHASE3CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2014

Conditions
Iron Deficiency AnaemiaInflammatory Bowel DiseaseCrohn's Disease
Interventions
DRUG

ST10

30 mg capsules to be taken orally twice a day for 12 weeks in double-blind phase

DRUG

Placebo oral capsule

Matching placebo capsules for ST10 to be taken orally twice a day for 12 weeks in double-blind phase

Sponsors
All Listed Sponsors
lead

Shield Therapeutics

INDUSTRY